Literature DB >> 12594663

Bone marrow micrometastasis in breast cancer.

S Ozbas1, H Dafydd, A D Purushotham.   

Abstract

BACKGROUND: Several studies have demonstrated that bone marrow micrometastasis in patients with breast cancer is an independent prognostic factor for systemic recurrence and poorer survival.
METHODS: This review describes the detection and clinical significance of micrometastatic cells in bone marrow, and examines the correlation between such micrometastasis and established clinicopathological prognostic factors. The relevant English language literature on bone marrow micrometastasis in breast cancer was searched via Medline (1975-2002), cross-referencing with key articles on the subject. RESULTS AND
CONCLUSION: The balance of evidence favours the hypothesis that bone marrow micrometastasis impacts on disease-free and overall survival. Further prospective studies are required to examine this in greater detail, with particular reference to early node-negative breast cancer and the value of adjuvant systemic therapy in patients with bone marrow micrometastasis. Copyright 2003 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 12594663     DOI: 10.1002/bjs.4107

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  6 in total

Review 1.  Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy.

Authors:  Wende Kozlow; Theresa A Guise
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-04       Impact factor: 2.673

2.  Detection of cancer cells disseminated in bone marrow using real-time quantitative RT-PCR of CEA, CK19, and CK20 mRNA in patients with gastric cancer.

Authors:  Yasuki Fujita; Masanori Terashima; Yutaka Hoshino; Satoshi Ohtani; Seigo Kashimura; Norio Kanzaki; Fumihiko Osuka; Michihiko Kogure; Mitsukazu Gotoh
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

3.  Role of Plasma D-Dimer Levels in Breast Cancer Patients and Its Correlation with Clinical and Histopathological Stage.

Authors:  Harish S; Raxith Sringeri R; Sarath Chandra P
Journal:  Indian J Surg Oncol       Date:  2017-08-08

Review 4.  Breast cancer, stem cells and prospects for therapy.

Authors:  Magnus D Lynch; Massimiliano Cariati; Anand D Purushotham
Journal:  Breast Cancer Res       Date:  2006-07-03       Impact factor: 6.466

5.  Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes: possible relevance to the assays for the detection of micrometastatic breast cancer.

Authors:  A Ballestrero; A Garuti; M Bertolotto; I Rocco; D Boy; A Nencioni; L Ottonello; F Patrone
Journal:  Br J Cancer       Date:  2005-05-23       Impact factor: 7.640

6.  Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer.

Authors:  Ina H Benoy; Roberto Salgado; Hilde Elst; Peter Van Dam; Joost Weyler; Eric Van Marck; Simon Scharpé; Peter B Vermeulen; Luc Y Dirix
Journal:  Breast Cancer Res       Date:  2005-01-10       Impact factor: 6.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.